Latest Price of Capivasertib (2026)

Capivasertib belongs to a class of medications known as antineoplastic agents. It interferes with the growth of cancer cells and ultimately leads to their destruction.

Latest Price of Capivasertib (2026)

Capivasertib produced by Lucius Pharmaceuticals offers patients two commonly used specifications to meet the needs of different treatment stages and individualized medication regimens: besides the standard 160mg64 tablets, it also provides the 200mg64 tablets option.

The specific price of the drug may fluctuate due to factors such as purchase channels, regions, medical insurance policies, market supply and demand, and promotional activities.

If you need further information about Capivasertib, including its indications and medication guidelines, or if you have purchase intentions, please feel free to contact us through the homepage of our official website. We will provide you with professional pharmaceutical consultation and purchase assistance services. Thank you for your attention and trust in Lucius Pharmaceuticals.

Precautions Before Taking Capivasertib

The decision to use a medication requires a careful weighing of its potential risks against its expected benefits. This is a joint decision to be made by you and your doctor. For this medication, the following factors should be taken into consideration:

Hypersensitivity

Inform your doctor if you have ever had any unusual or allergic reaction to this medication or any other drugs. Also, inform your healthcare provider if you have any other types of allergies, such as allergies to foods, dyes, preservatives, or animals. For over-the-counter products, carefully read the ingredient list on the label or packaging.

Pediatric Use

Adequate studies to determine the relationship between age and the efficacy of Capivasertib in the pediatric population have not been conducted. Its safety and effectiveness in this group have not been established.

Geriatric Use

Appropriate studies performed to date have not demonstrated geriatric-specific issues that would limit the use of Capivasertib in the elderly.

Lactation

There are insufficient studies available to confirm the risk of this medication to infants when used by breastfeeding women. The potential benefits and risks should be carefully weighed before using this medication during breastfeeding.

What to Do If You Miss a Dose of Capivasertib

If you miss a dose and it is within 4 hours of your usual dosing time, take the missed dose as soon as possible. Then resume your regular dosing schedule. If you miss a dose and more than 4 hours have passed since your usual dosing time, skip the missed dose and return to your regular dosing schedule.

If you vomit after taking a dose, do not take an extra dose. Wait and take your next scheduled dose as usual.